NYSE:CHE
Chemed Corp Stock News
$568.00
+1.49 (+0.263%)
At Close: Apr 30, 2024
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
09:31am, Thursday, 25'th Apr 2024
Chemed's (CHE) first-quarter 2024 results reflect VITAS' impressive revenue growth and improved average revenues per patient per day.
Chemed (CHE) Q1 Earnings Miss Estimates
07:10pm, Wednesday, 24'th Apr 2024
Chemed (CHE) came out with quarterly earnings of $5.20 per share, missing the Zacks Consensus Estimate of $5.47 per share. This compares to earnings of $4.82 per share a year ago.
Here's Why You Should Retain Chemed (CHE) Stock for Now
11:31am, Wednesday, 17'th Apr 2024
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care
10:00am, Thursday, 14'th Mar 2024
Chemed's (CHE) VITAS segment is set to acquire the hospice assets of Covenant Care in Florida and Alabama.
Chemed Corporation to Present at the Oppenheimer 34th Annual Healthcare Conference
12:00pm, Friday, 08'th Mar 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 34th Annual Healthcare Conference on Tuesday, March 12, 2024,
Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Monday, 04'th Mar 2024
Chemed (CHE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ADUS vs. CHE: Which Stock Is the Better Value Option?
12:46pm, Thursday, 29'th Feb 2024
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two companies is the b
Chemed (CHE) Q4 Earnings Surpass Estimates, Margins Expand
07:41am, Thursday, 29'th Feb 2024
Chemed's (CHE) fourth-quarter 2023 performance reflects an improvement in VITAS' operational metrics.
Chemed (CHE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
09:01pm, Tuesday, 27'th Feb 2024
The headline numbers for Chemed (CHE) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimat
Chemed (CHE) Tops Q4 Earnings Estimates
08:16pm, Tuesday, 27'th Feb 2024
Chemed (CHE) came out with quarterly earnings of $6.60 per share, beating the Zacks Consensus Estimate of $6.25 per share. This compares to earnings of $5.39 per share a year ago.
Chemed To Report Fourth-Quarter 2023 Earnings February 27, Related Conference Call To Be Held On February 28
12:00pm, Wednesday, 14'th Feb 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2023, on Tuesday, February 27, 2024, follow
Here's Why You Should Retain Chemed (CHE) Stock for Now
09:31am, Monday, 22'nd Jan 2024
Investors continue to be optimistic about Chemed (CHE) on the strength of the VITAS Healthcare and Roto-Rooter segments.
Chemed (CHE) Roto-Rooter Growth Continues, Macro Issues Hurt
12:47pm, Monday, 08'th Jan 2024
Within the Hospice segment, Chemed (CHE) is well poised to register growth driven by the growing aging population.
Chemed Corporation to Present at the 42nd Annual JPMorgan Healthcare Conference
12:00pm, Friday, 29'th Dec 2023
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 42nd Annual JPMorgan Healthcare Conference on Monday, January 8, 2024, at approxim
DVA vs. CHE: Which Stock Is the Better Value Option?
12:47pm, Wednesday, 27'th Dec 2023
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either DaVita HealthCare (DVA) or Chemed (CHE). But which of these two stocks offers value in
